Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA announces recall of blood tests due to 'significant concerns' | Cardiologists worth at least $5M
Tuesday, July 6, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces recall of blood lead tests due to 'significant concerns'

Any patients assessed by these tests may need to have their results reviewed by a specialist.  

READ MORE >
Finger stick | Blood
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of blood lead tests due to 'significant concerns'

Share on Twitter Share on Facebook Share on Linkedin
Finger stick | Blood
Any patients assessed by these tests may need to have their results reviewed by a specialist.  
READ MORE >

7% of cardiologists worth at least $5M—more than almost any other specialty

The report also found that 18% of cardiologists are still paying off their student loans.

READ MORE >
Money
Share on Twitter Share on Facebook Share on Linkedin

7% of cardiologists worth at least $5M—more than almost any other specialty

Share on Twitter Share on Facebook Share on Linkedin
Money
The report also found that 18% of cardiologists are still paying off their student loans.
READ MORE >

Featured Articles

Cardiologist makes history, completes LAAO with new 3D ICE catheter

An interventional cardiologist at Mayo Clinic in Rochester, Minnesota, carried out the procedure. 

READ MORE >
The Philips Verisight 3D/4D ICE catheter can help guide LAA occlusion and TEER procedures without the need for TEE.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist makes history, completes LAAO with new 3D ICE catheter

Share on Twitter Share on Facebook Share on Linkedin
The Philips Verisight 3D/4D ICE catheter can help guide LAA occlusion and TEER procedures without the need for TEE.
An interventional cardiologist at Mayo Clinic in Rochester, Minnesota, carried out the procedure. 
READ MORE >

Risk score predicts outcomes for heart failure patients undergoing TEER

The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period. 

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

Risk score predicts outcomes for heart failure patients undergoing TEER

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period. 
READ MORE >

Abbott gains key DAPT approvals for Xience stents in US, Europe

DAPT for patients at a high risk of bleeding can now be as short as 28 days with the Xience line of stents, the company announced. 

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Abbott gains key DAPT approvals for Xience stents in US, Europe

Share on Twitter Share on Facebook Share on Linkedin
approved approval
DAPT for patients at a high risk of bleeding can now be as short as 28 days with the Xience line of stents, the company announced. 
READ MORE >

Diabetes drug tirzepatide associated with ‘significant improvements’ as Eli Lilly prepares for FDA filing

Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Diabetes drug tirzepatide associated with ‘significant improvements’ as Eli Lilly prepares for FDA filing

Share on Twitter Share on Facebook Share on Linkedin
Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.
READ MORE >

In Other News

Notable regulatory approvals of emerging technologies over the past 30 days

Along with AI in its various iterations, the list may include virtual and augmented reality, 3D printing, robotics and other technologies currently changing healthcare delivery.

READ MORE >
approved_ok.png
Share on Twitter Share on Facebook Share on Linkedin

Notable regulatory approvals of emerging technologies over the past 30 days

Share on Twitter Share on Facebook Share on Linkedin
approved_ok.png
Along with AI in its various iterations, the list may include virtual and augmented reality, 3D printing, robotics and other technologies currently changing healthcare delivery.
READ MORE >

10 robots for cranial neurosurgery on the market or in the works

The authors concentrate on robotic technologies that either augment a surgeon’s movements or simplify a multistep process.

READ MORE >
i_robot.jpg
Share on Twitter Share on Facebook Share on Linkedin

10 robots for cranial neurosurgery on the market or in the works

Share on Twitter Share on Facebook Share on Linkedin
i_robot.jpg
The authors concentrate on robotic technologies that either augment a surgeon’s movements or simplify a multistep process.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme